| Literature DB >> 27958319 |
Hélène Kiefer1, Luc Jouneau1, Évelyne Campion1, Delphine Rousseau-Ralliard1, Thibaut Larcher2, Marie-Laure Martin-Magniette3,4,5, Sandrine Balzergue4, Mireille Ledevin2, Audrey Prézelin1, Pascale Chavatte-Palmer1, Yvan Heyman1, Christophe Richard1,6, Daniel Le Bourhis1, Jean-Paul Renard1, Hélène Jammes1.
Abstract
Cloning enables the generation of both clinically normal and pathological individuals from the same donor cells, and may therefore be a DNA sequence-independent driver of phenotypic variability. We took advantage of cattle clones with identical genotypes but different developmental abilities to investigate the role of epigenetic factors in perinatal mortality, a complex trait with increasing prevalence in dairy cattle. We studied livers from pathological clones dying during the perinatal period, clinically normal adult clones with the same genotypes as perinatal clones and conventional age-matched controls. The livers from deceased perinatal clones displayed histological lesions, modifications to quantitative histomorphometric and metabolic parameters such as glycogen storage and fatty acid composition, and an absence of birth-induced maturation. In a genome-wide epigenetic analysis, we identified DNA methylation patterns underlying these phenotypic alterations and targeting genes relevant to liver metabolism, including the type 2 diabetes gene TCF7L2. The adult clones were devoid of major phenotypic and epigenetic abnormalities in the liver, ruling out the effects of genotype on the phenotype observed. These results thus provide the first demonstration of a genome-wide association between DNA methylation and perinatal mortality in cattle, and highlight epigenetics as a driving force for phenotypic variability in farmed animals.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27958319 PMCID: PMC5153653 DOI: 10.1038/srep38869
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Altered histological structure of the liver in pathological perinatal clones.
(A) Liver sections stained with haemalin-eosin-saffron are shown for one AI control foetus, one cloned foetus, one control calf and one cloned calf. Fibrotic areas are revealed by their yellow appearance following saffron staining. The arrows indicate disorganization of the rows of hepatocytes and the asterisks highlight examples of intracytoplasmic lipid vesicles corresponding to mild steatosis. Scale bar: 25 μm. (B) Thirty animals were graded in categories according to the severity of seven types of lesions (Tables 1 and 2), and MCA was performed. Categories containing fewer than four individuals were merged, generating G1G2, S1S2, A2A3, and I1I2. Upper left panel: barplot of the contribution of each dimension to total variance, showing a marked drop between the first and second dimensions and then smaller drops. Upper right panel: variable factor map, illustrating the contribution of each variable to dimensions 1 and 2. Lower panel: individual and category factor map, with 95% confidence ellipses shown for each group. The proximity of individuals to a category indicates that this category is more represented among these individuals than in the remaining population. (C,D) For each animal, the area and a shape factor representing circularity (1: perfect circles) were measured on at least 200 hepatocyte nuclei and the mean (C) and CV (D) were calculated. The CV is indicative of cell heterogeneity in the tissue. Each dot represents one animal. Median values are indicated by horizontal lines. Open dots: perinatal AI controls; filled dots: perinatal clones. Prenatal (circles) and postnatal (squares) animals were considered separately. Significant differences between AI and clones and between prenatal and postnatal animals are indicated (p < 0.05, permutation test). (E) For perinatal animals with clearly observable cell limits, the cell area and shape factor were measured on 35 hepatocytes, and the mean was calculated. The differences between AI controls and clones were not significant.
Animals.
| Animal | Breed/Genotype | Sex | Age | Cause of death/phenotype | Parity/ Lactations | Histological characterization | Morphometrical measurements | Fatty acid composition | Methylation assay |
|---|---|---|---|---|---|---|---|---|---|
| Foetus AI | |||||||||
| Holstein | F | GD267 | Slaughter of the mother/Normal | 0/0 | R0, F2, G2, S0, C0, A1, I0 | Nucleus, Cell | PL, NL | Microarray, pyrosequencing | |
| Holstein | M | GD267 | Slaughter of the mother/Normal | 0/0 | R0, F0, G2, S0, C0, A1, I0 | Nucleus, Cell | PL, NL | Microarray, pyrosequencing | |
| Holstein | M | GD266 | Slaughter of the mother/Normal | 0/0 | R0, F0, G2, S0, C0, A1, I0 | Nucleus, Cell | PL, NL | Microarray, pyrosequencing | |
| Holstein | F | GD266 | Slaughter of the mother/Normal | 0/0 | R0, F0, G2, S0, C0, A3, I0 | Nucleus, Cell | PL, NL | Microarray, pyrosequencing | |
| Foetus clone | |||||||||
| 92 | Holstein/5538 | F | GD263 | Spontaneous death after C-section/Hydrops | 0/0 | R2, F3, G0, S0, C1, A0, I0 | Nucleus, Cell | PL, NL | Pyrosequencing |
| Holstein/2251 | F | GD268 | Spontaneous abortion/Hydronephros | 0/0 | R2, F3, G0, S1, C2, A1, I0 | Nucleus, Cell | PL, NL | Microarray, pyrosequencing | |
| Holstein/2251 | F | GD263 | Slaughter of the recipient/Hydrops | 0/0 | R2, F3, G2, S0, C1, A2, I0 | Nucleus | PL, NL | Microarray, pyrosequencing | |
| Holstein/5538 | F | GD257 | Spontaneous abortion/Hydrops | 0/0 | R2, F3, G0, S1, C2, A2, I0 | Nucleus, Cell | PL, NL | Microarray, pyrosequencing | |
| Holstein/5538 | F | GD273 | Stillborn at C-section/Hydrops | 0/0 | R2, F2, G0, S1, C0, A2, I0 | Nucleus, Cell | NL | Microarray, pyrosequencing | |
| Holstein/5538 | F | GD273 | Stillborn at C-section/Hydrops | 0/0 | R2, F0, G0, S2, C2, A2, I0 | Nucleus, Cell | PL, NL | Microarray, pyrosequencing | |
| Calf AI | |||||||||
| 1171 | Holstein | F | PD4 | Slaughter/Normal | 0/0 | R1, F0, G0, S2, C0, A1, I0 | Nucleus, Cell | PL, NL | Pyrosequencing |
| 1226 | Holstein | F | PD4 | Slaughter/Normal | 0/0 | R0, F0, G2, S0, C0, A0, I0 | Nucleus, Cell | PL, NL | Pyrosequencing |
| 3594 | Holstein | F | PD4 | Slaughter/Free Martin | 0/0 | R0, F0, G2, S0, C0, A1, I0 | Nucleus, Cell | PL, NL | Pyrosequencing |
| Calf clone | |||||||||
| 40 | Holstein/5538 | F | Term (GD279) | Slaughter 1 h after birth/Severe limb deformities | 0/0 | R0, F0, G2, S0, C0, A0, I0 | Nucleus, Cell | PL, NL | Pyrosequencing |
| 61 | Holstein/5538 | F | Term (GD281) | Spontaneous death 5 min. after birth/Cardiac failure | 0/0 | R0, F0, G2, S0, C0, A0, I0 | Nucleus, Cell | PL, NL | Pyrosequencing |
| 76 | Holstein/5538 | F | PD2 | Spontaneous death/Kidney dysfunction? | 0/0 | PL, NL | Pyrosequencing | ||
| Holstein/2251 | F | Term (GD281) | Spontaneous death 6 h after birth/Internal haemorrhage | 0/0 | R1, F3, G2, S0, C2, A0, I0 | PL, NL | Microarray, pyrosequencing | ||
| Holstein/5538 | F | PD4 | Slaughter/Limb deformities | 0/0 | PL, NL | Microarray, pyrosequencing | |||
| Adult AI | |||||||||
| Holstein | F | 10 years | Slaughter/Normal | 7/7 | R0, F0, G0, S0, C0, A0, I1 | Nucleus | PL, NL | Microarray, pyrosequencing | |
| 29 | Holstein/0029 | F | 10 years | Slaughter/Normal | 1/1 | R1, F0, G0, S0, C0, A0, I0 | Nucleus | PL, NL | |
| Holstein | F | 8 years | Slaughter/Normal | 5/5 | PL, NL | Microarray, pyrosequencing | |||
| Holstein | F | 6 years | Slaughter/Normal | 4/3 | R0, F0, G0, S0, C0, A1, I0 | Nucleus | Microarray, pyrosequencing | ||
| Holstein | F | 6 years | Slaughter/Normal | 2/2 | R0, F0, G0, S0, C0, A0, I1 | PL, NL | Microarray, pyrosequencing | ||
| Holstein | F | 6 years | Slaughter/Normal | 2/2 | R1, F2, G0, S0, C0, A2, I1 | PL, NL | Microarray, pyrosequencing | ||
| Holstein | F | 5 years | Slaughter/Normal | 1/1 | R0, F0, G0, S0, C0, A0, I1 | Nucleus | PL, NL | Microarray, pyrosequencing | |
| Holstein | F | 7 years | Slaughter/Normal | PL, NL | Microarray, pyrosequencing | ||||
| Holstein/5538 | F | 15 years | Slaughter/Limb injury | 7/6 | R1, F2, G0, S0, C0, A1, I0 | Nucleus | PL, NL | Microarray, pyrosequencing | |
| Adult clone | |||||||||
| 139 | Holstein/7711 | F | 11 years | Slaughter/Normal | 0/0 | PL, NL | Pyrosequencing | ||
| Holstein/5538 | F | 6 years | Slaughter/Limb infection | 3/3 | R0, F2, G0, S0, C0, A0, I2 | Nucleus | PL, NL | Microarray, pyrosequencing | |
| Holstein/0029 | F | 6 years | Slaughter/Normal | 2/2 | R0, F2, G0, S0, C0, A0, I1 | Nucleus | PL, NL | Microarray, pyrosequencing | |
| Holstein/2251 | F | 4 years | Slaughter/abnormal kidney | 1/0 | R0, F2, G0, S0, C0, A0, I0 | Nucleus | PL, NL | Microarray, pyrosequencing | |
| Holstein/0029 | F | 5 years | Slaughter/Normal | 2/2 | R0, F0, G0, S0, C0, A0, I0 | PL, NL | Microarray, pyrosequencing | ||
| Holstein/5538 | F | 5 years | Slaughter/Normal | 2/2 | R0, F2, G0, S0, C0, A1, I2 | Nucleus | PL, NL | Microarray, pyrosequencing | |
| 474 | Holstein/2251 | F | 8.5 years | Slaughter/Normal | 4/3 | PL, NL | Pyrosequencing | ||
| Holstein/5538 | F | 3.5 years | Slaughter/Limb injury, abnormal kidney | 1/1 | R0, F2, G0, S0, C0, A0, I1 | Nucleus | PL, NL | Microarray, pyrosequencing | |
| Holstein/5538 | F | 3 years | Slaughter/Limb injury | 1/1 | R0, F2, G2, S0, C0, A0, I1 | Nucleus | PL, NL | Microarray, pyrosequencing | |
F: female; M: male; GD: gestational day; PD: postnatal day; NA: not assessed; PL: phospholipids; NL: neutral lipids. In the “Histological characterization” column, animals are graded according to the severity of their lesions (see Table 2). The following parameters were inspected: R: alteration of cell rows (Remak trabeculae); F: fibrosis; G: glycogen storage; S: steatosis; C: anisocytosis; A: aspect of sinusoidal capillaries and aneurysm; I: inflammation.
*Microarray cohort.
1Two foetuses developed but only one was included in the study.
2Same recipient cow.
3Cell donors for nuclear transfer (same genotype as some of the clones).
Scoring of histopathological features.
| Histopathological feature | Score | Description |
|---|---|---|
| Alteration of rows of hepatocytes (Remak trabeculae) | R0 | No alteration |
| R1 | Only centrolobular trabeculae visible | |
| R2 | No trabeculae | |
| Fibrosis | F0 | Absent |
| F1 | Bridging portal fibrosis | |
| F2 | Dissecting fibrosis | |
| F3 | Marked bridging fibrosis with nodules | |
| Glycogen storage in hepatocytes | G0 | Absent |
| G1 | Focal | |
| G2 | Diffuse | |
| Steatosis in hepatocytes | S0 | Absent |
| S1 | Focal | |
| S2 | Diffuse | |
| Anisocytosis of hepatocytes | C0 | Absent |
| C1 | Present | |
| C2 | Present with some atypic cells | |
| Aspect of sinusoidal capillaries | A0 | Even diameter |
| A1 | Focal dilatation | |
| A2 | Mild aneurysm | |
| A3 | Important aneurysm | |
| Inflammation | I0 | Absent |
| I1 | Mild | |
| I2 | Important |
Figure 2Altered FA composition in the livers of pathological perinatal clones.
(A) The total amount of FAs was measured by gas chromatography in phospholipids and neutral lipids and expressed as mg/g liver. Each dot represents one animal. Open dots: perinatal AI controls; filled dots: perinatal clones. Prenatal (circles) and postnatal (squares) animals were considered separately. Significant differences between prenatal and postnatal animals are indicated (p < 0.05, permutation test). PL; phospholipids; NL: neutral lipids. (B) For 22 FAs each measured on 34 individuals and detected in both adults and perinatal animals, PCA was run on FA percentages converted to rankings in order to homogenize the distributions. Left panel: barplot of the contribution of each dimension to total variance; middle panel; variable factor map with FAs belonging to phospholipids and neutral lipids shown in red and blue, respectively; right panel: individual factor map with 95% confidence ellipses shown for each group. (C) The ratio between C22:6ω3 and C20:4ω6 was determined in the phospholipids and neutral lipids of each animal. Significant differences between perinatal AI and perinatal clones are indicated, as are significant differences between prenatal and postnatal animals (p < 0.05, permutation test).
Figure 3Altered biological age of the liver in pathological perinatal clones.
Phenotypic measurements on hepatocyte nuclei (A) or FA levels and composition (B) are plotted against chronological age, assessed as the interval in days between conception (AI for controls, nuclear transfer for clones) and death/necropsy. This measurement of chronological age allows a representation of prenatal animals (open dots) and postnatal animals (filled dots) on the same graph, independently of the timing of birth. The black circles and red triangles indicate perinatal AI controls and perinatal clones, respectively. The least squares lines of best fit and Spearman’s rank correlation coefficients r are shown in black and red for perinatal AI controls and perinatal clones, respectively. Significant correlations (Spearman’s rank correlation test; p < 0.05) are indicated by plain lines and correlation coefficients in bold letters, whereas non-significant correlations (p ≥ 0.05) are indicated by dotted lines and correlation coefficients in italics. PL: phospholipids; NL: neutral lipids; ω6PUFA: omega 6 polyunsaturated FAs.
Figure 4Age-related DMRs underlie the normal transition to adult life.
(A) MFA was run on a subset of animals using three sets of quantitative variables: DMR (methylation at age-related DMRs and cloning-related DMRs, 282 variables; Supplementary Information), Morpho (histomorphometric parameters; 4 variables) and FA (FA features in phospholipids and neutral lipids; 48 variables). The group (adult AI, adult clone, foetus AI and foetus clone) was set as the illustrative variable. Left panel: graphic display of individuals in the principal plane of MFA (mean representation of individuals according to the three datasets). Right panel: representation of each set of variables including the illustrative variable in the principal plane of MFA, with contributions to dimensions 1 and 2 given by the coordinates of their projections on the x-axis and y-axis, respectively. (B) 182 variables of the DMR set were significantly correlated to dimension 1 of MFA. The graph indicates the distribution of these variables (in blue) among age-related DMRs and cloning-related DMRs. (C) Variables of the Morpho set (in red) and FA set (in green) that were the most highly significantly correlated to dimension 1 of MFA are listed. Correlation coefficients with dimension 1 of MFA (n = 17 individuals; correlation coefficients produced as an output of MFA) and with average DNA methylation at age-related DMRs and cloning-related DMRs (n = 19 to 25; Spearman’s rank correlation coefficients) are given in the Dim 1, Age-related DMRs and Cloning-related DMRs columns. For age-related DMRs and cloning-related DMRs, the variables tested for correlations with phenotypic variables are Piage and Picloning for individual i, respectively (see Methods). For a significant correlation (p < 0.05) the correlation coefficient is underlined, and is otherwise displayed in italics. Nu: histomorphometric measurements on hepatocyte nuclei; PL: phospholipid fraction; NL: neutral lipid fraction; ω3/ω6: ratio between omega 3 and omega 6 polyunsaturated FAs.
Figure 5A subset of age-related DMRs and cloning-related DMRs underlie abnormal liver physiology.
(A) MFA was run on seven foetuses using three sets of quantitative variables: DMR (methylation at age-related DMRs and cloning-related DMRs, 282 variables), Morpho (histomorphometric parameters, 8 variables) and FA (FA features, 56 variables). The group (foetus AI and foetus clone) was set as the illustrative variable. Left panel: graphic display of individuals in the principal plane of MFA (mean representation of individuals according to the three datasets). Right panel: representation of each set of variables including the illustrative variable in the principal plane of MFA. (B) Variables of the DMR set significantly correlated to dimension 1 of MFA (in blue) were evenly distributed among age-related DMRs and cloning-related DMRs. (C) Variables of the Morpho set (in red) and FA set (in green) that were significantly correlated to dimension 1 of MFA are listed. Correlation coefficients with dimension 1 of MFA (n = 7 individuals; correlation coefficients produced as an output of MFA) and with average DNA methylation at age-related DMRs and cloning-related DMRs (n = 8 to 11; Spearman’s rank correlation coefficients) are given in the Dim 1, Age-related DMRs and Cloning-related DMRs columns. For a significant correlation (p < 0.05) the correlation coefficient is underlined, and is otherwise displayed in italics. Nu: histomorphometric measurements on hepatocyte nuclei; Cell: histomorphometric measurements on hepatocytes; PL: phospholipids; NL: neutral lipids. (D) Significant correlations between four phenotypic variables shown in (C) and average DNA methylation at age-related DMRs and cloning-related DMRs. Each dot corresponds to one animal. The x-axis represents the average percentage of enriched probes Pi calculated for each animal i at DMRs (left panel: Piage; right panel: Picloning).
Figure 6DMRs associated with abnormal liver physiology target genes involved in the response to stress and energy metabolism.
(A) GO analysis performed using PANTHER on the 148 DMRs significantly correlated to dimension 1 of MFA and contributing to the separation between cloned and AI foetuses. Terms of biological processes displaying a statistical over-representation among the DMRs are indicated, as are the corresponding genes. Genes shown in B and in Fig. 7A are underlined. (B) IGV browser views showing regions targeted by the microarray for genes involved in energy metabolism (G6PC3, PPP5C, LDHA, SIRT2, INSIG2 and NDUFA4), fibrosis (COL1A1) and inflammation (IL6ST and NFKBIB). The blue, grey, black and green bar charts represent the proportions of enriched probes at each probe position for the four groups of animals. Orange boxes indicate the regions of interest selected for differential analysis as defined in the Supplementary Methods. CpGs are shown, as are the probe classes based on CpG frequency (the upper, middle and lower bands represent high, intermediate and low class probes, respectively). DMRs are indicated by red boxes.
Figure 7TCF7L2 methylation and expression are deregulated in pathological perinatal clones.
(A) IGV browser view showing the region targeted by the microarray for TCF7L2. The blue, grey, black and green bar charts represent the proportions of enriched probes at each probe position for the four groups of animals. The DMR is indicated by a red box. (B) Average methylation level of six CpGs assayed by pyrosequencing for perinatal AI (n = 7), perinatal clones (n = 11), adult AI (n = 8) and adult clones (n = 9). For each box, the middle line indicates the median and the edges the 25th/75th percentiles. Significant differences between groups are indicated (p < 0.05, permutation test for pairwise comparisons). (C) Significant correlations between five phenotypic variables described in Fig. 5C and DNA methylation at TCF7L2 DMR are shown (p < 0.05; Spearman’s rank correlation test). Each dot corresponds to one animal. The least squares lines of best fit and correlation coefficients are indicated. The x-axis represents the average percentage of methylation of six CpGs belonging to the TCF7L2 DMR and obtained by pyrosequencing. Cell area is used as an indirect measure of the glycogen content of hepatocytes. Nu: histomorphometric measurements on hepatocyte nuclei; Cell: histomorphometric measurements on hepatocytes; PL: phospholipids; NL: neutral lipids. (D) The expression of TCF7L2 was assessed by quantitative PCR. Left panel: the relative expression of TCF7L2 was reduced in perinatal clones compared to perinatal controls (p < 0.05, permutation test). Right panel: positive correlation between DNA methylation assessed by pyrosequencing and expression (p < 0.05; Spearman’s rank correlation test).